GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

BI 456906

Company
Boehringer Ingelheim
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
4 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

4 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for BI 456906 and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT06632444

    LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

    Not yet reported Boehringer Ingelheim 1800 participants Est. completion 2031-12-27 528 sites
    MASH Other conditions: Liver Fibrosis
    View official trial listing →
  • Recruiting NCT NCT06632457

    LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

    Not yet reported Boehringer Ingelheim 1590 participants Est. completion 2029-06-05 445 sites
    MASH
    View official trial listing →
  • Recruiting NCT NCT07754461

    A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

    Not yet reported Boehringer Ingelheim 600 participants Est. completion 2028-05-01 121 sites
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT07768813

    A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity

    Not yet reported Boehringer Ingelheim 44 participants Est. completion 2026-12-22 1 site Stand-alone
    Other conditions: Healthy, Obesity
    View official trial listing →
  • Completed NCT NCT03175211

    Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 20 participants Est. completion 2018-02-19 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03591718

    A Study to Test Different Doses of BI 456906 in Patients With Obesity

    Not yet reported Boehringer Ingelheim 131 participants Est. completion 2020-04-30 2 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04153929

    A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

    Not yet reported Boehringer Ingelheim 413 participants Est. completion 2021-11-04 80 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04384081

    A Study to Test How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2

    Not yet reported Boehringer Ingelheim 37 participants Est. completion 2021-01-20 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04667377

    A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

    Not yet reported Boehringer Ingelheim 387 participants Est. completion 2022-10-07 43 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04771273

    A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

    Not yet reported Boehringer Ingelheim 295 participants Est. completion 2023-12-21 154 sites
    MASH
    View official trial listing →
  • Active, not recruiting NCT NCT05202353

    A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

    Not yet reported Boehringer Ingelheim 29 participants Est. completion 2027-02-03 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05296733

    A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906

    Not yet reported Boehringer Ingelheim 82 participants Est. completion 2023-12-29 13 sites Stand-alone
    Other conditions: Healthy, Liver Diseases, Obesity
    View official trial listing →
  • Completed NCT NCT05421338

    A Study in Healthy Men to Test How BI 456906 is Processed in the Body

    Not yet reported Boehringer Ingelheim 6 participants Est. completion 2022-11-17 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05751226

    A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906

    Not yet reported Boehringer Ingelheim 88 participants Est. completion 2024-08-01 1 site Stand-alone
    Other conditions: Healthy, Obesity
    View official trial listing →
  • Completed NCT NCT05896384

    A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

    Not yet reported Boehringer Ingelheim 32 participants Est. completion 2025-03-26 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06066515

    A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

    Not yet reported Boehringer Ingelheim 726 participants Est. completion 2026-02-20 118 sites
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06066528

    A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

    Not yet reported Boehringer Ingelheim 755 participants Est. completion 2026-04-01 143 sites
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06077864

    A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

    Not yet reported Boehringer Ingelheim 5531 participants Est. completion 2026-06-30 539 sites
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06176365

    A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease

    Not yet reported Boehringer Ingelheim 274 participants Est. completion 2025-12-03 28 sites
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06200467

    A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

    Not yet reported Boehringer Ingelheim 110 participants Est. completion 2025-10-22 1 site Stand-alone
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT06214741

    A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight

    Not yet reported Boehringer Ingelheim 307 participants Est. completion 2026-01-28 28 sites
    Other conditions: Obesity, Overweight
    View official trial listing →
  • Completed NCT NCT06352411

    A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems

    Not yet reported Boehringer Ingelheim 42 participants Est. completion 2025-09-16 2 sites Stand-alone
    Other conditions: Healthy, Renal Impairment
    View official trial listing →
  • Completed NCT NCT06352424

    A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity

    Not yet reported Boehringer Ingelheim 23 participants Est. completion 2025-02-24 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06564441

    A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity

    Not yet reported Boehringer Ingelheim 34 participants Est. completion 2026-01-05 1 site
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT06745284

    A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity

    Not yet reported Boehringer Ingelheim 64 participants Est. completion 2027-01-10 2 sites
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06772532

    A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body

    Not yet reported Boehringer Ingelheim 30 participants Est. completion 2025-06-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07071974

    A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2025-10-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT07206290

    Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease

    Not yet reported University Medical Center Groningen 120 participants Est. completion 2027-11-30 Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT07221591

    A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

    Not yet reported Boehringer Ingelheim 100 participants Est. completion 2026-07-28 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT07407348

    A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

    Not yet reported Boehringer Ingelheim 80 participants Est. completion 2027-03-02 1 site
    Other conditions: Healthy, Obesity, Overweight
    View official trial listing →
  • Completed NCT NCT07413913

    A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector

    Not yet reported Boehringer Ingelheim 56 participants Est. completion 2026-06-11 1 site
    Other conditions: Healthy, Obesity
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.